Price-file publication check · 45 CFR § 180
C · 70
This hospital's published file contains part of what § 180 requires.
●Machine-readable file published: assessment threshold met
○Gross / standard charges: below assessment threshold
○Discounted cash price: below assessment threshold
●Payer-specific negotiated rates: assessment threshold met
●Min / max negotiated charges: assessment threshold met
●Free, public, no login required: assessment threshold met
Procedures listed
15,827
Insurances with rates
7
CPT / HCPCS codes
12,144
Most expensive procedures (gross)
36100961
$98,326
HC REVSC EVASC FPVT ATHRC UNI SF LES 1ST VSL
Gross
$131,101
36100963
$98,326
HC REVSC EVASC FPVT ATHRC UNI CPLX LES 1ST VSL
Gross
$131,101
36100965
$98,326
HC REVSC EVASC FPVT ST ATHRC UNI SF LES 1ST VSL
Gross
$131,101
36100967
$98,326
HC REVSC EVASC FPVT ST ATHRC UNI CPLX LES 1ST VSL
Gross
$131,101
36100962
$73,744
HC REVSC EVASC FPVT ATHRC UNI SF LES EA ADDL VSL
Gross
$98,326
36100964
$73,744
HC REVSC EVASC FPVT ATHRC UNI CPLX LES EA ADDL VSL
Gross
$98,326
36100966
$73,744
HC REVSC EVASC FPVT ST ATHRC UNI SF LES EA ADDL VSL
Gross
$98,326
36100968
$73,744
HC REVSC EVSC FPVT ST ATHRC UNI CPLX LES EA ADD VSL
Gross
$98,326
36100969
$73,744
HC INTRAVASCULAR LITHOTRIPSY FPVT W/IN SAME ARTERY
Gross
$98,326
214804
$65,186
ocrelizumab 30 mg/mL Soln 10 mL Vial
Gross
$86,915
36100947
$61,920
HC REVSC EVASC IVT ST PLMT UNI SF LES 1ST VSL UNILAT
Gross
$82,560
36100948
$61,920
HC REVSC EVASC IVT ST PLMT UNI SF LES 1ST VSL BILAT
Gross
$82,560
36100950
$61,920
HC REVSC EVASC IVT ST PLMT UNI CPLX LES 1ST VSL
Gross
$82,560
36100957
$61,920
HC REVSC EVASC FPVT ST PLMT UNI SF LES 1ST VSL
Gross
$82,560
36100959
$61,920
HC REVSC EVASC FPVT ST PLMT UNI CPLX LES 1ST VSL
Gross
$82,560
224756
$55,304
teprotumumab-trbw 500 mg Solr 1 each Vial
Gross
$73,739
173998
$54,068
ecallantide 10 mg/mL (1 mL) Soln 3 mL Vial
Gross
$72,091
36100958
$46,440
HC REVSC EVASC FPVT ST PLMT UNI SF LES EA ADDL VSL
Gross
$61,920
36100960
$46,440
HC REVSC EVASC FPVT ST PLMT UNI CPLX LES EA ADD VSL
Gross
$61,920
175682
$45,350
cabazitaxel 10 mg/mL (first dilution) Soln 6 mL Vial
Gross
$60,467
174193
$44,655
ustekinumab 45 mg/0.5 mL Syrg 0.5 mL Syringe
Gross
$59,540
174194
$44,655
ustekinumab 90 mg/mL Syrg 1 mL Syringe
Gross
$59,540
226014
$43,954
pertuzumab-trastuzumab-hy-zzxf 1,200 mg-600mg- 30000 unit/15mL Soln 15 mL Vial
Gross
$58,605
238355
$31,522
tarlatamab-dlle 10 mg Solr 1 each Vial
Gross
$42,029
36100943
$30,528
HC REVSC EVASC IVT ANGIO SF 1ST VSL
Gross
$40,704
36100945
$30,528
HC REVSC EVASC IVT ANGIOP UNI CPLX LES 1ST VSL
Gross
$40,704
163213
$30,205
lanreotide 120 mg/0.5 mL Syrg 0.5 mL Syringe
Gross
$40,273
36000038
$28,208
HC LITHOTRIPSY, UNILATERAL
Gross
$37,611
73690
$26,966
alteplase 100 mg Solr 1 each Vial
Gross
$35,955
36000037
$25,768
HC LITHOTRIPSY, BILATERAL
Gross
$34,357
218546
$25,425
tenecteplase 50 mg Solr 1 each Vial
Gross
$33,900
174459
$23,331
collagenase 0.9 mg Solr 1 each Vial
Gross
$31,109
36100944
$22,896
HC REVSC EVASC IVT ANGIOP UNI SF LES EA ADDL VSL
Gross
$30,528
36100946
$22,896
HC REVSC EVASC IVT ANGIOP UNI CPLX LES EA ADDL VSL
Gross
$30,528
168112
$22,205
Panitumumab 400 mg/20 mL (20 mg/mL) Soln 20 mL Vial
Gross
$29,607
225589
$22,112
daratumumab-hyaluronidase-fihj 1,800 mg-30,000 unit/15 mL Soln 15 mL Vial
Gross
$29,482
233135
$21,951
teclistamab-cqyv 90 mg/mL Soln 1.7 mL Vial
Gross
$29,268
201384
$20,050
octreotide microspheres 30 mg Serr 1 each Vial
Gross
$26,733
193605
$19,678
vedolizumab 300 mg Solr 1 each Vial
Gross
$26,237
800104
$18,990
ALTEPLASE INFUSION (STROKE) 100 mL Bag
Gross
$25,320
179582
$18,664
ipilimumab 50 mg/10 mL (5 mg/mL) Soln 10 mL Vial
Gross
$24,885
192292
$18,109
obinutuzumab 1,000 mg/40 mL Soln 40 mL Vial
Gross
$24,145
167671
$17,396
romiPLOStim 500 mcg Solr 1 each Vial
Gross
$23,195
229515
$17,191
anifrolumab-fnia 300 mg/2 mL (150 mg/mL) Soln 2 mL Vial
Gross
$22,922
71324
$16,562
leuprolide 11.25 mg Sykt 1 each KIT
Gross
$22,083
217817
$16,375
nivolumab 240 mg/24 mL Soln 24 mL Vial
Gross
$21,834
202248
$14,708
immune globulin 10 % Soln 400 mL Vial
Gross
$19,610
74755
$14,576
digoxin immune fab 40 mg Solr 1 each Vial
Gross
$19,435
185038
$14,345
pertuzumab 420 mg/14 mL (30 mg/mL) Soln 14 mL Vial
Gross
$19,126
214912
$13,573
durvalumab 50 mg/mL Soln 10 mL Vial
Gross
$18,097
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 36100961 | HC REVSC EVASC FPVT ATHRC UNI SF LES 1ST VSL | $131,101 | $98,326 | — | — | 0 |
| 36100963 | HC REVSC EVASC FPVT ATHRC UNI CPLX LES 1ST VSL | $131,101 | $98,326 | — | — | 0 |
| 36100965 | HC REVSC EVASC FPVT ST ATHRC UNI SF LES 1ST VSL | $131,101 | $98,326 | — | — | 0 |
| 36100967 | HC REVSC EVASC FPVT ST ATHRC UNI CPLX LES 1ST VSL | $131,101 | $98,326 | — | — | 0 |
| 36100962 | HC REVSC EVASC FPVT ATHRC UNI SF LES EA ADDL VSL | $98,326 | $73,744 | — | — | 0 |
| 36100964 | HC REVSC EVASC FPVT ATHRC UNI CPLX LES EA ADDL VSL | $98,326 | $73,744 | — | — | 0 |
| 36100966 | HC REVSC EVASC FPVT ST ATHRC UNI SF LES EA ADDL VSL | $98,326 | $73,744 | — | — | 0 |
| 36100968 | HC REVSC EVSC FPVT ST ATHRC UNI CPLX LES EA ADD VSL | $98,326 | $73,744 | — | — | 0 |
| 36100969 | HC INTRAVASCULAR LITHOTRIPSY FPVT W/IN SAME ARTERY | $98,326 | $73,744 | — | — | 0 |
| 214804 | ocrelizumab 30 mg/mL Soln 10 mL Vial | $86,915 | $65,186 | — | — | 0 |
| 36100947 | HC REVSC EVASC IVT ST PLMT UNI SF LES 1ST VSL UNILAT | $82,560 | $61,920 | — | — | 0 |
| 36100948 | HC REVSC EVASC IVT ST PLMT UNI SF LES 1ST VSL BILAT | $82,560 | $61,920 | — | — | 0 |
| 36100950 | HC REVSC EVASC IVT ST PLMT UNI CPLX LES 1ST VSL | $82,560 | $61,920 | — | — | 0 |
| 36100957 | HC REVSC EVASC FPVT ST PLMT UNI SF LES 1ST VSL | $82,560 | $61,920 | — | — | 0 |
| 36100959 | HC REVSC EVASC FPVT ST PLMT UNI CPLX LES 1ST VSL | $82,560 | $61,920 | — | — | 0 |
| 224756 | teprotumumab-trbw 500 mg Solr 1 each Vial | $73,739 | $55,304 | — | — | 0 |
| 173998 | ecallantide 10 mg/mL (1 mL) Soln 3 mL Vial | $72,091 | $54,068 | — | — | 0 |
| 36100958 | HC REVSC EVASC FPVT ST PLMT UNI SF LES EA ADDL VSL | $61,920 | $46,440 | — | — | 0 |
| 36100960 | HC REVSC EVASC FPVT ST PLMT UNI CPLX LES EA ADD VSL | $61,920 | $46,440 | — | — | 0 |
| 175682 | cabazitaxel 10 mg/mL (first dilution) Soln 6 mL Vial | $60,467 | $45,350 | — | — | 0 |
| 174193 | ustekinumab 45 mg/0.5 mL Syrg 0.5 mL Syringe | $59,540 | $44,655 | — | — | 0 |
| 174194 | ustekinumab 90 mg/mL Syrg 1 mL Syringe | $59,540 | $44,655 | — | — | 0 |
| 226014 | pertuzumab-trastuzumab-hy-zzxf 1,200 mg-600mg- 30000 unit/15mL Soln 15 mL Vial | $58,605 | $43,954 | — | — | 0 |
| 238355 | tarlatamab-dlle 10 mg Solr 1 each Vial | $42,029 | $31,522 | — | — | 0 |
| 36100943 | HC REVSC EVASC IVT ANGIO SF 1ST VSL | $40,704 | $30,528 | — | — | 0 |
| 36100945 | HC REVSC EVASC IVT ANGIOP UNI CPLX LES 1ST VSL | $40,704 | $30,528 | — | — | 0 |
| 163213 | lanreotide 120 mg/0.5 mL Syrg 0.5 mL Syringe | $40,273 | $30,205 | — | — | 0 |
| 36000038 | HC LITHOTRIPSY, UNILATERAL | $37,611 | $28,208 | — | — | 0 |
| 73690 | alteplase 100 mg Solr 1 each Vial | $35,955 | $26,966 | — | — | 0 |
| 36000037 | HC LITHOTRIPSY, BILATERAL | $34,357 | $25,768 | — | — | 0 |
| 218546 | tenecteplase 50 mg Solr 1 each Vial | $33,900 | $25,425 | — | — | 0 |
| 174459 | collagenase 0.9 mg Solr 1 each Vial | $31,109 | $23,331 | — | — | 0 |
| 36100944 | HC REVSC EVASC IVT ANGIOP UNI SF LES EA ADDL VSL | $30,528 | $22,896 | — | — | 0 |
| 36100946 | HC REVSC EVASC IVT ANGIOP UNI CPLX LES EA ADDL VSL | $30,528 | $22,896 | — | — | 0 |
| 168112 | Panitumumab 400 mg/20 mL (20 mg/mL) Soln 20 mL Vial | $29,607 | $22,205 | — | — | 0 |
| 225589 | daratumumab-hyaluronidase-fihj 1,800 mg-30,000 unit/15 mL Soln 15 mL Vial | $29,482 | $22,112 | — | — | 0 |
| 233135 | teclistamab-cqyv 90 mg/mL Soln 1.7 mL Vial | $29,268 | $21,951 | — | — | 0 |
| 201384 | octreotide microspheres 30 mg Serr 1 each Vial | $26,733 | $20,050 | — | — | 0 |
| 193605 | vedolizumab 300 mg Solr 1 each Vial | $26,237 | $19,678 | — | — | 0 |
| 800104 | ALTEPLASE INFUSION (STROKE) 100 mL Bag | $25,320 | $18,990 | — | — | 0 |
| 179582 | ipilimumab 50 mg/10 mL (5 mg/mL) Soln 10 mL Vial | $24,885 | $18,664 | — | — | 0 |
| 192292 | obinutuzumab 1,000 mg/40 mL Soln 40 mL Vial | $24,145 | $18,109 | — | — | 0 |
| 167671 | romiPLOStim 500 mcg Solr 1 each Vial | $23,195 | $17,396 | — | — | 0 |
| 229515 | anifrolumab-fnia 300 mg/2 mL (150 mg/mL) Soln 2 mL Vial | $22,922 | $17,191 | — | — | 0 |
| 71324 | leuprolide 11.25 mg Sykt 1 each KIT | $22,083 | $16,562 | — | — | 0 |
| 217817 | nivolumab 240 mg/24 mL Soln 24 mL Vial | $21,834 | $16,375 | — | — | 0 |
| 202248 | immune globulin 10 % Soln 400 mL Vial | $19,610 | $14,708 | — | — | 0 |
| 74755 | digoxin immune fab 40 mg Solr 1 each Vial | $19,435 | $14,576 | — | — | 0 |
| 185038 | pertuzumab 420 mg/14 mL (30 mg/mL) Soln 14 mL Vial | $19,126 | $14,345 | — | — | 0 |
| 214912 | durvalumab 50 mg/mL Soln 10 mL Vial | $18,097 | $13,573 | — | — | 0 |
Showing top 50 of 15,827 priced procedures, sorted by gross charge.
Data straight from this hospital's own published price file (45 CFR § 180). The grade scores how completely the file contains the six required data elements. It is a check of the file — not a CMS compliance ruling, and not a measure of quality of care.